These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35393874)

  • 21. The Impact of Mobile Health Use on the Self-care of Patients With Type 2 Diabetes: Protocol for a Randomized Controlled Trial.
    Gosak L; Pajnkihar M; Stiglic G
    JMIR Res Protoc; 2022 Jun; 11(6):e31652. PubMed ID: 35713944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group.
    Fleming GA; Petrie JR; Bergenstal RM; Holl RW; Peters AL; Heinemann L
    Diabetes Care; 2020 Jan; 43(1):250-260. PubMed ID: 31806649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group.
    Fleming GA; Petrie JR; Bergenstal RM; Holl RW; Peters AL; Heinemann L
    Diabetologia; 2020 Feb; 63(2):229-241. PubMed ID: 31802144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of supported telemetric monitoring in people with type 2 diabetes: study protocol for a randomised controlled trial.
    Wild S; Hanley J; Lewis S; McKnight J; McCloughan L; Padfield P; Paterson M; Pinnock H; McKinstry B
    Trials; 2013 Jul; 14():198. PubMed ID: 23829417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lifestyle changes and glycemic control in type 1 diabetes mellitus: a trial protocol with factorial design approach.
    Sawani S; Siddiqui AR; Azam SI; Humayun K; Ahmed A; Habib A; Naz S; Tufail M; Iqbal R
    Trials; 2020 Apr; 21(1):346. PubMed ID: 32312302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving pain treatment with a smartphone app: study protocol for a randomized controlled trial.
    Suso-Ribera C; Mesas Á; Medel J; Server A; Márquez E; Castilla D; Zaragozá I; García-Palacios A
    Trials; 2018 Feb; 19(1):145. PubMed ID: 29482614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self-monitoring of Blood Glucose in Non-Insulin Treated Type 2 Diabetes (The SMBG Study): study protocol for a randomised controlled trial.
    Parsons S; Luzio S; Bain S; Harvey J; McKenna J; Khan A; Rice S; Watkins A; Owens DR
    BMC Endocr Disord; 2017 Jan; 17(1):4. PubMed ID: 28143495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Smartphone App as Motivational Intervention to Improve Glycemic Control in Adolescents with Type 1 Diabetes.
    Pramanik BK; Angelin JJ; Mathai VJ; Mathai S; Korula S; Simon A
    Indian J Pediatr; 2019 Dec; 86(12):1118-1123. PubMed ID: 31353430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and evaluation of a tailored e-self-management intervention (dr. Bart app) for knee and/or hip osteoarthritis: study protocol.
    Pelle T; Bevers K; van der Palen J; van den Hoogen FHJ; van den Ende CHM
    BMC Musculoskelet Disord; 2019 Aug; 20(1):398. PubMed ID: 31472687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Qatar Diabetes Mobile Application Trial (QDMAT): an open-label randomised controlled trial to examine the impact of using a mobile application to improve diabetes care in type 2 diabetes mellitus-a study protocol.
    Suleiman N; Alkasem M; Al Amer Z; Salameh O; Al-Thani N; Hamad MK; Baagar K; Abdalhakam I; Othman M; Dughmosh R; Al-Mohanadi D; Al Sanousi A; Bashir M; Chagoury O; Taheri S; Abou-Samra AB
    Trials; 2022 Jun; 23(1):504. PubMed ID: 35710428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Digital Support for Healthier Eating Habits Among Patients With Type 2 Diabetes: Protocol for a Randomized Clinical Trial Within Primary Care (HAPPY Trial).
    Trolle Lagerros Y; Dahlgren A; Sjöblom L; Bonn SE
    JMIR Res Protoc; 2020 Nov; 9(11):e24422. PubMed ID: 33196448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of smartphone application-based self-management interventions in patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials.
    He Q; Zhao X; Wang Y; Xie Q; Cheng L
    J Adv Nurs; 2022 Feb; 78(2):348-362. PubMed ID: 34324218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Outcomes Among Working Adults Using the Health Integrator Smartphone App: Analyses of Prespecified Secondary Outcomes in a Randomized Controlled Trial.
    Bonn S; Licitra G; Bellocco R; Trolle Lagerros Y
    J Med Internet Res; 2022 Mar; 24(3):e24725. PubMed ID: 35311677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mobile Applications to Support Diabetes Self-Management Education: Patient Experiences and Provider Perspectives.
    Krall JS; Childs B; Mehrotra N
    J Diabetes Sci Technol; 2023 Sep; 17(5):1206-1211. PubMed ID: 37162000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study protocol for a randomized controlled trial to test for preventive effects of diabetic foot ulceration by telemedicine that includes sensor-equipped insoles combined with photo documentation.
    Ming A; Walter I; Alhajjar A; Leuckert M; Mertens PR
    Trials; 2019 Aug; 20(1):521. PubMed ID: 31439007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rethinking Models of Outpatient Specialist Care in Type 2 Diabetes Using eHealth: Study Protocol for a Pilot Randomised Controlled Trial.
    Menon A; Fatehi F; Bird D; Darssan D; Karunanithi M; Russell A; Gray L
    Int J Environ Res Public Health; 2019 Mar; 16(6):. PubMed ID: 30889802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrated Diabetes Self-Management Program Using Smartphone Application: A Randomized Controlled Trial.
    Kim Y; Lee H; Seo JM
    West J Nurs Res; 2022 Apr; 44(4):383-394. PubMed ID: 33655794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. App-technology to increase physical activity among patients with diabetes type 2 - the DiaCert-study, a randomized controlled trial.
    Bonn SE; Alexandrou C; Hjörleifsdottir Steiner K; Wiklander K; Östenson CG; Löf M; Trolle Lagerros Y
    BMC Public Health; 2018 Jan; 18(1):119. PubMed ID: 29316905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.